Biomea Fusion Valuation
| BMEA Stock | USD 2.73 0.20 7.91% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Biomea Fusion shows a prevailing Real Value of $12.15 per share. The current price of the firm is $2.73. Our model approximates the value of Biomea Fusion from analyzing the firm fundamentals such as Return On Equity of -1.05, shares owned by insiders of 25.01 %, and Current Valuation of 12.94 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Biomea Fusion's valuation include:
Undervalued
Today
Please note that Biomea Fusion's price fluctuation is somewhat reliable at this time. Calculation of the real value of Biomea Fusion is based on 3 months time horizon. Increasing Biomea Fusion's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Biomea Fusion is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biomea Stock. However, Biomea Fusion's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.73 | Real 12.15 | Target 40.56 | Hype 2.57 | Naive 2.73 |
The real value of Biomea Stock, also known as its intrinsic value, is the underlying worth of Biomea Fusion Company, which is reflected in its stock price. It is based on Biomea Fusion's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Biomea Fusion's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Biomea Fusion helps investors to forecast how Biomea stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biomea Fusion more accurately as focusing exclusively on Biomea Fusion's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Biomea Fusion's intrinsic value based on its ongoing forecasts of Biomea Fusion's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Biomea Fusion's closest peers. If more than one evaluation category is relevant for Biomea Fusion we suggest using both methods to arrive at a better estimate.
Biomea Fusion Cash |
|
Biomea Valuation Trend
Comparing Biomea Fusion's enterprise value against its market capitalization is a good way to estimate the value of Biomea Fusion uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Biomea Fusion Total Value Analysis
Biomea Fusion is currently forecasted to have valuation of 12.94 M with market capitalization of 91.68 M, debt of 10.3 M, and cash on hands of 149.63 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Biomea Fusion fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
12.94 M | 91.68 M | 10.3 M | 149.63 M |
Biomea Fusion Asset Utilization
One of the ways to look at asset utilization of Biomea is to check how much profit was generated for every dollar of assets it reports. Biomea Fusion shows a negative utilization of assets of -0.56 percent, losing $0.005638 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Biomea Fusion shows how discouraging it operates for each dollar spent on its assets.Biomea Fusion Ownership Allocation
Biomea Fusion holds a total of 36.24 Million outstanding shares. Over half of Biomea Fusion's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Biomea Fusion Profitability Analysis
Net Loss for the year was (117.25 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Biomea Fusion's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Biomea Fusion and how it compares across the competition.
About Biomea Fusion Valuation
The stock valuation mechanism determines Biomea Fusion's current worth on a weekly basis. Our valuation model uses a comparative analysis of Biomea Fusion. We calculate exposure to Biomea Fusion's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Biomea Fusion's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -3.8 M | -3.6 M |
Biomea Fusion Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 34.1 M |
Biomea Fusion Current Valuation Indicators
Valuation refers to the process of determining the present value of Biomea Fusion and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Biomea we look at many different elements of the entity such as Biomea's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Biomea Fusion, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Biomea Fusion's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Biomea Fusion's worth.Complementary Tools for Biomea Stock analysis
When running Biomea Fusion's price analysis, check to measure Biomea Fusion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomea Fusion is operating at the current time. Most of Biomea Fusion's value examination focuses on studying past and present price action to predict the probability of Biomea Fusion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomea Fusion's price. Additionally, you may evaluate how the addition of Biomea Fusion to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |